Researchers from Boston’s Mass General Brigham reviewed medical records from almost 150,000 pregnancies between June 2016 and ...

The study is part of the Infant Development Environment and Lifestyle (IDEAL) Study, a multi-site, longitudinal study of prenatal MA exposure and infant and childhood outcomes. The IDEAL study ...

Researchers said more should be done to weigh the pros and cons of taking weight loss drugs around the time of pregnancy. View on euronews ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

Women who stop taking GLP-1 medications just prior to a pregnancy appear to be at higher odds for weight gain and complications, researchers said.

A new study suggests that stopping GLP-1 medications before pregnancy may be linked to higher rates of complications and gestational weight gain. Experts caution that the findings don't prove ...

Researchers determine the risk of pregnancy weight gain in patients who were prescribed GLP-1 RAs prior to conception.